Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Apr 28;56:19. doi: 10.1186/s40659-023-00430-9

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2023

Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

PMC Copyright notice

Fig. 3 — KO of ambra1b leads to decreased PGC number. (A, B) Quantification of PGCs in 10-hpf embryos of ambra1a (A), ambra1b (B) genotypes, expressed as percentage of PGCs in heterozygous and homozygous siblings compared to their WT controls. Histograms show data pooled together from three independent experiments. Only ambra1b^−/− embryos show significant reduction of PGC number (ambra1a^+/+ n = 36, ambra1a^+/− n = 78, ambra1a^−/− n = 35; ambra1b^+/+ n = 21, ambra1b^+/− n = 54, ambra1b^−/− n = 29). Statistical analysis was performed using One way ANOVA. *, P < 0.05. (C) Percentage of PGCs in WT embryos injected with ambra1a or ambra1b ATG MOs or splicing MOs. Analysis was performed at 10 hpf by immunohistochemistry for Vasa protein. ambra1b knockdown performed with both types of MO results in a significant reduction of PGCs. Histograms show data pooled together from three independent experiments (WT n = 23, MO-ambra1a-ATG n = 14, MO-ambra1b-ATG n = 41, MO-ambra1a-splic n = 20, MO-ambra1b-splic n = 20). Statistical analysis was performed using One way ANOVA. *, P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. (D, E) Results of rescue experiments by co-injection of GFP-nos1-3’UTR mRNA with ambra1a or ambra1b mRNA, respectively. PGC number is expressed as percentage with respect to ambra1b^+/− animals, in which the PGC number was settled as 100%. Histograms show data pooled together from three independent experiments (D: ambra1b^+/− n = 38, ambra1b^−/− n = 35; E: ambra1b^+/− n = 28, ambra1b^−/− n = 34). Statistical analysis was performed using Student’s t-test. *** P < 0.001. (F) Quantification of PGC number in ambra1b^+/− and ambra1b^−/− embryos at 10, 24,72 hpf after injection with GFP-nos1-3’UTR mRNA. Number of PGCs in controls (ambra1b^+/−) was settled as 100%. Histograms show data pooled together from three independent experiments (10 hpf: ambra1b^+/− n = 25, ambra1b^−/− n = 31; 24 hpf: ambra1b^+/− n = 28, ambra1b^−/− n = 30; 72 hpf: ambra1b^+/− n = 29, ambra1b^−/− n = 38). Statistical analysis was performed using Student’s t-test. *** P < 0.001. Error bars indicate SEM.